Literature DB >> 22687670

Hepatic nodule: a case of primary myelofibrosis.

Filipe Sousa Cardoso1, João Veríssimo Pires, José Simão Miranda, João Mascarenhas Araújo.   

Abstract

Primary myelofibrosis is one of the entities that may manifest with lesions of extramedullary haematopoiesis, especially in spleen and liver. The authors report a case of primary myelofibrosis presenting incidentally as an intrahepatic focal lesion of extramedullary haematopoiesis, a rare occurrence that highlights the challenge of hepatic nodule differential diagnosis, and allows reflection about the diagnostic criteria and prognostic factors of this myeloproliferative disease.

Entities:  

Mesh:

Year:  2011        PMID: 22687670      PMCID: PMC4545091          DOI: 10.1136/bcr.05.2011.4220

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Typical and atypical presentations of extramedullary hemopoiesis.

Authors:  Christos S Georgiades; Edward G Neyman; Isaac R Francis; Michael B Sneider; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

2.  Focal intrahepatic extramedullary hematopoiesis presenting as fatty lesions.

Authors:  Pramod Gupta; Archana Naran; Yong H Auh; James S Chung
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959

Review 3.  Modern management of myelofibrosis.

Authors:  Francisco Cervantes
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

4.  Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.

Authors:  Brady L Stein; Alison R Moliterno
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

Review 5.  Advances in the therapy of chronic idiopathic myelofibrosis.

Authors:  Cecilia Arana-Yi; Alfonso Quintás-Cardama; Francis Giles; Deborah Thomas; Antonio Carrasco-Yalan; Jorge Cortes; Hagop Kantarjian; Srdan Verstovsek
Journal:  Oncologist       Date:  2006-09

6.  Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.

Authors:  Pierre Morel; Alain Duhamel; Benedicte Hivert; Laure Stalniekiewicz; Jean-Loup Demory; Brigitte Dupriez
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

7.  New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

Authors:  Francisco Cervantes; Brigitte Dupriez; Arturo Pereira; Francesco Passamonti; John T Reilly; Enrica Morra; Alessandro M Vannucchi; Ruben A Mesa; Jean-Loup Demory; Giovanni Barosi; Elisa Rumi; Ayalew Tefferi
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

8.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

Review 9.  Primary myelofibrosis: update on definition, pathogenesis, and treatment.

Authors:  Omar I Abdel-Wahab; Ross L Levine
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia.

Authors:  Mohamed Ali Jelali; Alain Luciani; Hicham Kobeiter; Serge Zafrani; Marie Christine Anglade; Benhalima Zegai; Dora Bachir; Alain Rahmouni
Journal:  Cancer Imaging       Date:  2006-11-28       Impact factor: 3.909

  10 in total
  2 in total

1.  Magnetic resonance imaging features of intrahepatic extramedullary hematopoiesis: Three case reports.

Authors:  Ma Luo; Jia-Wen Chen; Chuan-Miao Xie
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

2.  The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib.

Authors:  Douglas Tremblay; Juan Putra; Alexander Vogel; Adam Winters; Ronald Hoffman; Thomas D Schiano; Maria Isabel Fiel; John O Mascarenhas
Journal:  Case Rep Hematol       Date:  2019-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.